Logo image of ENX.PA

EURONEXT NV (ENX.PA) Stock Fundamental Analysis

EPA:ENX - Euronext Paris - Matif - NL0006294274 - Common Stock - Currency: EUR

144.4  +2.4 (+1.69%)

Fundamental Rating

5

Taking everything into account, ENX scores 5 out of 10 in our fundamental rating. ENX was compared to 111 industry peers in the Capital Markets industry. ENX scores excellent on profitability, but there are some minor concerns on its financial health. ENX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ENX had positive earnings in the past year.
ENX had a positive operating cash flow in the past year.
Each year in the past 5 years ENX has been profitable.
In the past 5 years ENX always reported a positive cash flow from operatings.
ENX.PA Yearly Net Income VS EBIT VS OCF VS FCFENX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

ENX has a Return On Assets (0.32%) which is in line with its industry peers.
ENX has a Return On Equity of 20.84%. This is amongst the best in the industry. ENX outperforms 89.09% of its industry peers.
ENX's Return On Invested Capital of 12.05% is amongst the best of the industry. ENX outperforms 89.09% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ENX is in line with the industry average of 7.99%.
The last Return On Invested Capital (12.05%) for ENX is above the 3 year average (6.82%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.32%
ROE 20.84%
ROIC 12.05%
ROA(3y)0.24%
ROA(5y)2.39%
ROE(3y)12.67%
ROE(5y)15.83%
ROIC(3y)6.82%
ROIC(5y)8.05%
ENX.PA Yearly ROA, ROE, ROICENX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

ENX has a better Profit Margin (36.48%) than 81.82% of its industry peers.
ENX's Profit Margin has improved in the last couple of years.
ENX's Operating Margin of 49.93% is amongst the best of the industry. ENX outperforms 88.18% of its industry peers.
ENX's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 49.93%
PM (TTM) 36.48%
GM N/A
OM growth 3Y1.34%
OM growth 5Y-0.82%
PM growth 3Y4.18%
PM growth 5Y1.95%
GM growth 3YN/A
GM growth 5YN/A
ENX.PA Yearly Profit, Operating, Gross MarginsENX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

5

2. Health

2.1 Basic Checks

ENX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ENX has been increased compared to 5 years ago.
Compared to 1 year ago, ENX has an improved debt to assets ratio.
ENX.PA Yearly Shares OutstandingENX.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ENX.PA Yearly Total Debt VS Total AssetsENX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

2.2 Solvency

ENX has an Altman-Z score of 0.07. This is a bad value and indicates that ENX is not financially healthy and even has some risk of bankruptcy.
ENX has a Altman-Z score of 0.07. This is comparable to the rest of the industry: ENX outperforms 45.45% of its industry peers.
The Debt to FCF ratio of ENX is 5.01, which is a neutral value as it means it would take ENX, 5.01 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.01, ENX is in the better half of the industry, outperforming 78.18% of the companies in the same industry.
ENX has a Debt/Equity ratio of 0.61. This is a neutral value indicating ENX is somewhat dependend on debt financing.
The Debt to Equity ratio of ENX (0.61) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 5.01
Altman-Z 0.07
ROIC/WACCN/A
WACCN/A
ENX.PA Yearly LT Debt VS Equity VS FCFENX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.00 indicates that ENX should not have too much problems paying its short term obligations.
The Current ratio of ENX (1.00) is better than 61.82% of its industry peers.
ENX has a Quick Ratio of 1.00. This is a normal value and indicates that ENX is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ENX (1.00) is better than 61.82% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
ENX.PA Yearly Current Assets VS Current LiabilitesENX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

4

3. Growth

3.1 Past

ENX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.91%, which is quite good.
Measured over the past years, ENX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.67% on average per year.
Looking at the last year, ENX shows a very negative growth in Revenue. The Revenue has decreased by -16.64% in the last year.
ENX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.09% yearly.
EPS 1Y (TTM)18.91%
EPS 3Y7.11%
EPS 5Y17.67%
EPS Q2Q%13.92%
Revenue 1Y (TTM)-16.64%
Revenue growth 3Y7.8%
Revenue growth 5Y19.09%
Sales Q2Q%14.08%

3.2 Future

The Earnings Per Share is expected to grow by 3.07% on average over the next years.
ENX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.40% yearly.
EPS Next Y6%
EPS Next 2Y5.61%
EPS Next 3Y6.31%
EPS Next 5Y3.07%
Revenue Next Year7.83%
Revenue Next 2Y6.26%
Revenue Next 3Y6.18%
Revenue Next 5Y4.4%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ENX.PA Yearly Revenue VS EstimatesENX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
ENX.PA Yearly EPS VS EstimatesENX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

ENX is valuated rather expensively with a Price/Earnings ratio of 21.27.
63.64% of the companies in the same industry are more expensive than ENX, based on the Price/Earnings ratio.
ENX's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.35.
With a Price/Forward Earnings ratio of 19.71, ENX is valued on the expensive side.
Based on the Price/Forward Earnings ratio, ENX is valued a bit cheaper than the industry average as 65.45% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.19. ENX is around the same levels.
Industry RankSector Rank
PE 21.27
Fwd PE 19.71
ENX.PA Price Earnings VS Forward Price EarningsENX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ENX is valued a bit cheaper than the industry average as 79.09% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ENX indicates a somewhat cheap valuation: ENX is cheaper than 79.09% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 24.22
EV/EBITDA 11.52
ENX.PA Per share dataENX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of ENX may justify a higher PE ratio.
PEG (NY)3.55
PEG (5Y)1.2
EPS Next 2Y5.61%
EPS Next 3Y6.31%

4

5. Dividend

5.1 Amount

ENX has a Yearly Dividend Yield of 2.03%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 4.46, ENX has a dividend in line with its industry peers.
ENX's Dividend Yield is comparable with the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 2.03%

5.2 History

The dividend of ENX is nicely growing with an annual growth rate of 11.82%!
Dividend Growth(5Y)11.82%
Div Incr Years4
Div Non Decr Years4
ENX.PA Yearly Dividends per shareENX.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

29.08% of the earnings are spent on dividend by ENX. This is a low number and sustainable payout ratio.
The dividend of ENX is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP29.08%
EPS Next 2Y5.61%
EPS Next 3Y6.31%
ENX.PA Yearly Income VS Free CF VS DividendENX.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
ENX.PA Dividend Payout.ENX.PA Dividend Payout, showing the Payout Ratio.ENX.PA Dividend Payout.PayoutRetained Earnings

EURONEXT NV

EPA:ENX (6/20/2025, 7:00:00 PM)

144.4

+2.4 (+1.69%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)07-31 2025-07-31
Inst Owners52.44%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap15.05B
Analysts74.55
Price Target148.48 (2.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.03%
Yearly Dividend2.46
Dividend Growth(5Y)11.82%
DP29.08%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.61%
Min EPS beat(2)5.12%
Max EPS beat(2)6.1%
EPS beat(4)4
Avg EPS beat(4)5.67%
Min EPS beat(4)4.05%
Max EPS beat(4)7.43%
EPS beat(8)8
Avg EPS beat(8)6.84%
EPS beat(12)11
Avg EPS beat(12)5.76%
EPS beat(16)14
Avg EPS beat(16)6.91%
Revenue beat(2)1
Avg Revenue beat(2)-0.18%
Min Revenue beat(2)-1.41%
Max Revenue beat(2)1.05%
Revenue beat(4)3
Avg Revenue beat(4)0.26%
Min Revenue beat(4)-1.41%
Max Revenue beat(4)1.05%
Revenue beat(8)4
Avg Revenue beat(8)-0.15%
Revenue beat(12)7
Avg Revenue beat(12)15.13%
Revenue beat(16)10
Avg Revenue beat(16)23.57%
PT rev (1m)9.43%
PT rev (3m)20.56%
EPS NQ rev (1m)-1.2%
EPS NQ rev (3m)6.6%
EPS NY rev (1m)0%
EPS NY rev (3m)3.01%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)6.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.2%
Valuation
Industry RankSector Rank
PE 21.27
Fwd PE 19.71
P/S 6.21
P/FCF 24.22
P/OCF 21.24
P/B 3.55
P/tB N/A
EV/EBITDA 11.52
EPS(TTM)6.79
EY4.7%
EPS(NY)7.33
Fwd EY5.07%
FCF(TTM)5.96
FCFY4.13%
OCF(TTM)6.8
OCFY4.71%
SpS23.26
BVpS40.73
TBVpS-17.76
PEG (NY)3.55
PEG (5Y)1.2
Profitability
Industry RankSector Rank
ROA 0.32%
ROE 20.84%
ROCE 15.99%
ROIC 12.05%
ROICexc 15.64%
ROICexgc N/A
OM 49.93%
PM (TTM) 36.48%
GM N/A
FCFM 25.62%
ROA(3y)0.24%
ROA(5y)2.39%
ROE(3y)12.67%
ROE(5y)15.83%
ROIC(3y)6.82%
ROIC(5y)8.05%
ROICexc(3y)8.95%
ROICexc(5y)12.69%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.05%
ROCE(5y)10.68%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y9.06%
ROICexc growth 5Y-11.21%
OM growth 3Y1.34%
OM growth 5Y-0.82%
PM growth 3Y4.18%
PM growth 5Y1.95%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 5.01
Debt/EBITDA 1.85
Cap/Depr 46.22%
Cap/Sales 3.6%
Interest Coverage 41.14
Cash Conversion 50.63%
Profit Quality 70.23%
Current Ratio 1
Quick Ratio 1
Altman-Z 0.07
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)56.3%
Cap/Depr(5y)51.18%
Cap/Sales(3y)6.45%
Cap/Sales(5y)5.35%
Profit Quality(3y)121.66%
Profit Quality(5y)112.44%
High Growth Momentum
Growth
EPS 1Y (TTM)18.91%
EPS 3Y7.11%
EPS 5Y17.67%
EPS Q2Q%13.92%
EPS Next Y6%
EPS Next 2Y5.61%
EPS Next 3Y6.31%
EPS Next 5Y3.07%
Revenue 1Y (TTM)-16.64%
Revenue growth 3Y7.8%
Revenue growth 5Y19.09%
Sales Q2Q%14.08%
Revenue Next Year7.83%
Revenue Next 2Y6.26%
Revenue Next 3Y6.18%
Revenue Next 5Y4.4%
EBIT growth 1Y-4.22%
EBIT growth 3Y9.25%
EBIT growth 5Y18.11%
EBIT Next Year25.83%
EBIT Next 3Y11.99%
EBIT Next 5Y7.59%
FCF growth 1Y-14.07%
FCF growth 3Y9.28%
FCF growth 5Y22.23%
OCF growth 1Y-14.22%
OCF growth 3Y9.23%
OCF growth 5Y22.8%